Aprea Therapeutics Inc (APRE)

Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	17.54%4.03	3.43	2.65	3.12	3.51
Operating Income/Loss	17.54%-4.03	-3.43	-2.64	-3.12	-3.39
Income Tax Expense/Benefit	-	-	-	-	-
	9.23%-3.59	-3.29	-2.46	-2.97	-3.24
Attributable To Parent	9.23%-3.59	-3.29	-2.46	-2.97	-3.24
Basic Average Shares	264.19%53.48	14.69	-	6.37	6.08
Diluted Average Shares	264.19%53.48	14.69	-	6.37	6.08
Basic Earnings Per Share	68.18%-0.07	-0.22	-	-0.47	-0.53
Diluted Earnings Per Share	68.18%-0.07	-0.22	-	-0.47	-0.53